Host–guest complexes of docetaxel, an anti-cancer drug

被引:0
|
作者
T. Lakshmi Kumar
Pooja Guleria
Peddy Vishweshwar
A. Sivalakshmidevi
J. Moses Babu
K. Vyas
Palle V. R. Acharyulu
N. M. Sekhar
B. Selva Kumar
机构
[1] Dr. Reddy’s Laboratories Ltd.,Department of Analytical Research, Discovery Research
[2] Dr. Reddy’s Laboratories Ltd.,Analytical Research and Development, Integrated Product Development
[3] Dr. Reddy’s Laboratories Ltd.,Research & Development, Integrated Product Development
关键词
Anti-cancer drug; Docetaxel; Host–guest complex; Hydrogen bond; Inclusion compound; Supramolecular chemistry;
D O I
暂无
中图分类号
学科分类号
摘要
Host–guest complexes of Docetaxel 1, an anti-cancer drug have been isolated and crystal structures are described. Docetaxel crystallized in the 1:1 molar ratio with n-butanol, dimethylformamide (DMF) and acetonitrile (ACN) during crystallization from the respective solvents. In all the three complexes (1 · n-butanol, 1 · DMF and 1 · ACN), docetaxel formed a host framework through hydrogen bonds and the guest solvent molecules occupied the channels. The host is hydrogen bonded to the guest molecules through hydroxyl moieties. Interestingly, 1 · n-butanol, 1 · DMF and a literature 1 · CH3OH · H2O (1:1:1) host–guest complexes are isomorphs. Further, 1 · ACN complex unit cell parameters are similar (same space group) to the marketed docetaxel trihydrate polymorph (form A).
引用
收藏
页码:261 / 269
页数:8
相关论文
共 50 条
  • [21] Host-Guest Inclusion System of Scutellarin with Polyamine--Cyclodextrin: Preparation, Characterisation, and Anti-Cancer Activity
    Ma, Xue
    Yang, Bo
    Zhao, Yulin
    Xie, Hudie
    Gong, Xiaoshun
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2015, 68 (06) : 946 - 955
  • [22] Host-guest inclusion systems of mangiferin and polyamine-β-cyclodextrins: Preparation, characterization and anti-cancer activity
    Liang, Jing
    Li, Fanjie
    Lin, Jieling
    Song, Shuang
    Liao, Xiali
    Gao, Chuanzhu
    Yang, Bo
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1193 : 207 - 214
  • [23] Anti-cancer drug sensitivity in sinonasal squamous cancer
    Garcia-Inclan, Cristina
    Lopez, Fernando
    Potes-Ares, Sira
    Llorente, Jose L.
    Hermsen, Mario
    CELLULAR ONCOLOGY, 2012, 35 : S46 - S46
  • [24] Preparation, characterisation and structures of copper(II) complexes of an asymmetric anti-cancer drug analogue
    Moubaraki, B
    Murray, KS
    Ranford, JD
    Vittal, JJ
    Wang, XB
    Xu, Y
    JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1999, (20): : 3573 - 3578
  • [25] PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents
    Senevirathne, Suchithra A.
    Washington, Katherine E.
    Biewer, Michael C.
    Stefan, Mihaela C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (03) : 360 - 370
  • [26] New platinum complexes for the anti-cancer armamentarium
    Lazo, JS
    Pittsburgh, U
    MOLECULAR INTERVENTIONS, 2005, 5 (06) : 334 - 334
  • [27] Macromolecular ruthenium complexes as anti-cancer agents
    Blunden, Bianca M.
    Thomas, Donald S.
    Stenzel, Martina H.
    POLYMER CHEMISTRY, 2012, 3 (10) : 2964 - 2975
  • [28] ψ-Bufarenogin, a lead compound of anti-cancer drug
    Ding, Jin
    Wang, Hongyang
    CELL CYCLE, 2015, 14 (17) : 2719 - 2720
  • [29] PET in anti-cancer drug development and therapy
    Kumar, Rakesh
    Lal, Neena
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (03) : 259 - 263
  • [30] NEW APPROACH TO ANTI-CANCER DRUG DEVELOPMENT
    LANDES, RC
    BRITISH JOURNAL OF CANCER, 1975, 31 (02) : 254 - 254